These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet-vessel wall interaction in health and disease. Löwenberg EC; Meijers JC; Levi M Neth J Med; 2010 Jun; 68(6):242-51. PubMed ID: 20558854 [TBL] [Abstract][Full Text] [Related]
3. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Gachet C Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565 [TBL] [Abstract][Full Text] [Related]
4. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy. Rozalski M; Nocun M; Watala C Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207 [TBL] [Abstract][Full Text] [Related]
5. Platelets and antiplatelet therapy in patients with diabetes mellitus. Arjomand H; Roukoz B; Surabhi SK; Cohen M J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Jennings LK Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875 [TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptors as targets for antiplatelet therapy. Hamilton JR Blood Rev; 2009 Mar; 23(2):61-5. PubMed ID: 18644663 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents in the prevention and therapy of thrombosis. Coller BS Annu Rev Med; 1992; 43():171-80. PubMed ID: 1580582 [TBL] [Abstract][Full Text] [Related]